A Study in Second Line Metastatic Colorectal Cancer

Clinical trial NCT01183780 · COMPLETED

Trial details

NCT number: NCT01183780
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2010-12-02
Primary completion: 2014-07-17
Enrollment: 1072

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.